Science Explorer Back to mapMap
Discussion
Company · Champaign · United States

Aptimmune Biologics (United States)

Research works
2
▼ 100% vs 2018-21
Citations
46
30.1 per fractional work
Top-10% rate
14.4%
all institutions 10.0%
Open access
54%
world 40%
International
22%
world 18%
Aptimmune Biologics (United States)

Not ranked overall: Aptimmune Biologics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Aptimmune Biologics (United States) work in?

In all years, 60% of research at Aptimmune Biologics (United States) is in Life Sciences, 40% in Health Sciences. Its largest fields are Agricultural and Biological Sciences (40%), Medicine (40%), Biochemistry, Genetics and Molecular Biology (20%).

Life Sciences60%Health Sciences40%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 3 fields, with their numbers
    1. Agricultural and Biological Sciences140.0%
    2. Biochemistry, Genetics and Molecular Biology020.0%
    1. Medicine140.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Aptimmune Biologics (United States)?

The most cited paper from Aptimmune Biologics (United States) is "A porcine macrophage cell line that supports high levels of replication of OURT88/3, an attenuated strain of African swine fever virus" (Raquel S. Portugal, Lynnette C. Goatley, Robert J. Husmann et al., 2020), with 42 citations. Next come "Comparison of ZMAC and MARC-145 Cell Lines for Improving Porcine Reproductive and Respiratory Syndrome Virus Isolation from Clinical Samples" (32) and "Development of a porcine reproductive and respiratory syndrome virus-like-particle-based vaccine and evaluation of its immunogenicity in pigs" (25).

Most cited papers
#PaperReleasedCitations
1 A porcine macrophage cell line that supports high levels of replication of OURT88/3, an attenuated strain of African swine fever virus Raquel S. Portugal, Lynnette C. Goatley, Robert J. Husmann et al. · Emerging Microbes & Infections Open access 2020 42
2 Comparison of ZMAC and MARC-145 Cell Lines for Improving Porcine Reproductive and Respiratory Syndrome Virus Isolation from Clinical Samples Wannarat Yim‐Im, Haiyan Huang, Jie Park et al. · Journal of Clinical Microbiology Open access 3 Dec 2020 32
3 Development of a porcine reproductive and respiratory syndrome virus-like-particle-based vaccine and evaluation of its immunogenicity in pigs Basavaraj Binjawadagi, Yashavanth Shaan Lakshmanappa, Longchao Zhu et al. · Archives of Virology 23 Mar 2016 25
4 Effect of the host cell line on the vaccine efficacy of an attenuated porcine reproductive and respiratory syndrome virus Gabriela Calzada-Nova, Robert J. Husmann, William M. Schnitzlein et al. · Veterinary Immunology and Immunopathology 10 May 2012 24
All 4 most cited papers, with filters and sorting

Which research topics does Aptimmune Biologics (United States) publish most on?

By volume: Viral gastroenteritis research and epidemiology, Animal Virus Infections Studies, Virus-based gene therapy research and SARS-CoV-2 and COVID-19 Research.

  1. 1 Viral gastroenteritis research and epidemiology Infectious Diseases 0 works
  2. 2 Animal Virus Infections Studies Animal Science and Zoology 0 works
  3. 3 Virus-based gene therapy research Genetics 0 works
  4. 4 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  5. 5 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
  6. 6 Animal Disease Management and Epidemiology Agronomy and Crop Science 0 works
  7. 7 Vector-Borne Animal Diseases Ecology, Evolution, Behavior and Systematics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available54.3%not open45.7%

World: 40% of research is openly available.

with international co-authors21.7%domestic only78.3%

World: 18% is written across borders.

How has Aptimmune Biologics (United States)'s research output changed?

Output in 2022-2025 was 100% lower than in 2018-2021.

20152020

Other research institutions in Champaign

All research institutions in Champaign

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Aptimmune Biologics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.